182 related articles for article (PubMed ID: 18458152)
1. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
Koldehoff M; Beelen DW; Elmaagacli AH
J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells.
Koldehoff M; Beelen DW; Elmaagacli AH
Cancer Gene Ther; 2014 Jul; 21(7):275-82. PubMed ID: 24903015
[TBL] [Abstract][Full Text] [Related]
4. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
5. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells].
Zhang X; Xu WH; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097
[TBL] [Abstract][Full Text] [Related]
6. Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells.
Mulkeen AL; Silva T; Yoo PS; Schmitz JC; Uchio E; Chu E; Cha C
Arch Surg; 2006 Apr; 141(4):367-74; discussion 374. PubMed ID: 16618894
[TBL] [Abstract][Full Text] [Related]
7. Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma.
Matsumoto G; Kushibiki T; Kinoshita Y; Lee U; Omi Y; Kubota E; Tabata Y
Cancer Sci; 2006 Apr; 97(4):313-21. PubMed ID: 16630124
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib.
Podar K; Shringarpure R; Tai YT; Simoncini M; Sattler M; Ishitsuka K; Richardson PG; Hideshima T; Chauhan D; Anderson KC
Cancer Res; 2004 Oct; 64(20):7500-6. PubMed ID: 15492276
[TBL] [Abstract][Full Text] [Related]
10. AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells.
Frost P; Shi Y; Hoang B; Lichtenstein A
Oncogene; 2007 Apr; 26(16):2255-62. PubMed ID: 17016437
[TBL] [Abstract][Full Text] [Related]
11. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
[TBL] [Abstract][Full Text] [Related]
12. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
Raskopf E; Vogt A; Sauerbruch T; Schmitz V
J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
[TBL] [Abstract][Full Text] [Related]
15. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro.
Mei J; Gao Y; Zhang L; Cai X; Qian Z; Huang H; Huang W
Exp Oncol; 2008 Mar; 30(1):29-34. PubMed ID: 18438338
[TBL] [Abstract][Full Text] [Related]
16. Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro.
Al-Abd AM; Lee SH; Kim SH; Cha JH; Park TG; Lee SJ; Kuh HJ
J Control Release; 2009 Jul; 137(2):130-5. PubMed ID: 19306899
[TBL] [Abstract][Full Text] [Related]
17. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
[TBL] [Abstract][Full Text] [Related]
18. [Effect of siRNA targeting c-Myc and VEGF on human colorectal cancer cells].
Tai JD; Wang GY; Liu TJ; Wang L; Li F
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):502-6. PubMed ID: 19742345
[TBL] [Abstract][Full Text] [Related]
19. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib.
Zhou L; Hou J; Fu W; Wang D; Yuan Z; Jiang H
Leuk Res; 2008 Nov; 32(11):1674-83. PubMed ID: 18485479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
